Home · Health · Sep 15 archive
FDA Launches Pilot Program to Speed Up Drug Approval
Confirmed
In Short: The Food and Drug Administration (FDA) has opened applications for a pilot program aimed at reducing the time it takes for drugmakers to begin human testing, as part of efforts to compete with global biotech industries.
The FDA announced the pilot program as part of Operation TrialBlazer, a Department of Health and Human Services initiative designed to shorten drug approval timelines.
The program, which is part of the FDA's broader efforts to compete with rapidly advancing biotech industries in countries like China and Australia, is now accepting applications.
The initiative is part of a larger push to streamline the drug development process, potentially leading to faster access to new treatments for patients.
While the program is focused on human testing, it is part of a broader strategy to improve the overall efficiency of the FDA's drug approval process.
The move comes as the FDA faces increasing pressure to reduce the lengthy and complex process of bringing new drugs to market.
What's confirmed
- The FDA announced the pilot program as part of Operation TrialBlazer, a Department of Health and Human Services initiative designed to shorten drug approval timelines.
- The program, which is part of the FDA's broader efforts to compete with rapidly advancing biotech industries in countries like China and Australia, is now accepting applications.
- The initiative is part of a larger push to streamline the drug development process, potentially leading to faster access to new treatments for patients.
- While the program is focused on human testing, it is part of a broader strategy to improve the overall efficiency of the FDA's drug approval process.
- The move comes as the FDA faces increasing pressure to reduce the lengthy and complex process of bringing new drugs to market.
What's still developing
- Test your knowledge with our new weekday mini crossword Margaret is a Washington correspondent covering the Food and Drug Administration and other federal health agencies.
- WASHINGTON — The Food and Drug Administration is opening applications for a pilot program designed to shorten the amount of time it takes for drugmakers to begin testing their products in humans, the agency announced Tuesday.
- To read the rest of this story subscribe to STAT+.
- You may opt out of receiving STAT communications at any time.
- Applying for tax-free childcare can save parents on expensive nursery fees but some find themselves chasing the taxman for approval.
- The exiled auxiliary bishop of Managua contrasts the Nicaraguan dictatorship’s empty claim of divine approval with the authentic example of self-sacrifice given by Jesus Christ.
- The Carbondale-based Wilderness Workshop and national nonprofit The Wilderness Society are suing the federal government, alleging that the Bureau of Land Management’s June approval of oil and gas lease sales in Colorado and Wyoming violated federal law and disregarded potential harm to big game migration corridors and environmentally sensitive areas.
- The suit was filed by the two conservation nonprofits in the United States District Court in Denver on Tuesday, Sept.